Connected Drug Delivery Devices Market (By Technology [Bluetooth, NFC], By Product [Connected Sensors, Integrated Connected Devices]; By Technology - Bluetooth, NFC, Other Technologies; By End-user - Healthcare Providers, Homecare Centers) - Global Industry Size, Share, Trends and Forecast 2018-2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 0

Introduction

The global connected drug delivery devices market is project worth $718.9 Billion in 2026 and the market is projected to showcase 26.1% CAGR during the forecast period. The market is driven by increasing penetration of Internet of Things (IoT) in healthcare sector.

Market Dynamics

Increase in acceptance to technology in healthcare sector is the key reason for the growth of the connected drug delivery devices market. Also, supportive government regulation for healthcare sector is positively impacting the growth of the industry and is expected to push the growth during the forecast period.

Connected drug delivery devices technological innovation that has bridged the unsought gap between healthcare and digital technology. The emergence of these ‘healthcare-cum-technology’ devices have addressed the soaring need for better diagnostics and targeted therapeutic tools. It has outpaced the conventional endoscopy by more convenient capsule endoscopy technology, which has now become the standard for non-invasive diagnosis of motility disorders. Moreover, it not only helps physicians in real-time patient monitoring through remote controlling options, but also works as a dose reminder for the patients. Recent success in targeted drug delivery for diseases such as Crohn’s disease, Colitis and Colon cancer has opened new avenues for connected drug delivery devices.

Market Insights

The global connected drug delivery devices market is expected to register substantial growth in the near future, attributed to an increased collaborations between research institutions and companies, licensing agreements and partnerships amongst companies and augmented R&D investment on connected drug delivery devices. Other factors that drive the connected drug delivery devices market are rising prevalence of motility disorders, colon cancer, sedentary lifestyle, encouraging reimbursement environment, high patient compliance due to minimally invasive techniques, targeted drug delivery, and remote patient monitoring. However, factors such as high costs, limited technical knowledge and the patient’s expectations are likely to restrain the growth of the market.

Market Classification

The global connected drug delivery devices market is segmented into four major segment named product, end-user, technology, and region. On the basis of product the connected drug delivery devices market is segmented into connected sensors and integrated connected devices. These connected sensors are further bifurcated into inhaler sensors and injection sensors, and the integrated connected devices is also further segmented into integrated inhaler, and integrated injection. On the basis of the end-user the global connected drug delivery devices market is segmented into healthcare providers and homecare centers. On the basis of technology, the connected drug delivery devices market is segmented into bluetooth, NFC, other technologies (cellular, low power wide area network) On the basis of region the global connected drug delivery devices market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Regional Insights

In 2017, North America captured largest revenue share and the region is projected to continue its dominance over the forecast period as the region is highly active towards the adoption of modern technology. Other reason for the growth of the North America connected drug delivery market are high per capita healthcare expenditure, and increasing awareness about the adverse effects of non-adherence to medication.

Europe is projected to be the second fastest-developing market for connected drug delivery devices. Augmented incidence of chronic diseases and incidence of a huge target population base are the key parameter increasing demand for connected drug delivery devices in the region. Asia Pacific, Latin America, and Middle East and Africa, the need for connected drug delivery devices is anticipated to remain low during forecast period. This is due to less awareness of better healthcare facilities.

Report Coverage

Market

Connected Drug Delivery Devices Market

Analysis Period

2016 – 2026

Historic Data

2016 – 2017

Base Year

2018

Forecast Data

2019 – 2026

Market Stratification

Product, End-user, Technology  and Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis, 

Player Profiling, Value Chain Analysis

Market Participants

The major players associated with the connected drug delivery devices market Proteus Digital Health, Propeller Health, Merck, Adherium, and BIOCORP. Most of these enterprises put emphasis on new product launch and technological expansion, mergers & acquisitions, and strategic partnership activities as part of their commercial development strategies. Players associated with connected drug delivery market are continuously focussing on research and development to cater best to the customer and facilitate best technology to healthcare sector.

Market Segmentation

Market By Product

  • Connected Sensors
    • Inhaler Sensors
    • Injection Sensors
  • Integrated Connected Devices
    • Integrated Inhaler
    • Integrated Injection

Market By Technology

  • Bluetooth
  • NFC
  • Other Technologies (Cellular, Low Power Wide Area Network)

Market By End-user

  • Healthcare Providers
  • Homecare Centers

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA


Related Reports

Medical Nonwoven Disposables Market (By Product: Incontinence Hygiene Products, Surgical Non-woven Products; By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Platform) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

The global medical nonwoven disposables market is forecasted to grow at a CAGR of 6.6% over the forecast time frame and reach around US$ 26.1 billion by 2026. The report provides analysis of global medical non-woven disposables market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights Nonwovens are a unique category of textile product enginee

Plastic Surgery Instruments Market (By Type: Handheld Surgical Instruments, Electrosurgical Instruments; By Procedure: Face and Head Procedures, Breast Procedures, Body and Extremities Procedures, Reconstruction Surgeries) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global plastic surgery instruments market size is anticipated to reach around US$ 1.7 billion by 2026 and expected to grow at a CAGR of 8.5% from period 2019 to 2026. Plastic surgery involves the restoration, replacement, alteration and rehabilitation of body regions, such as the head, skin, musculoskeletal, breast and others. The two main kinds of plastic surgery are cosmetic and reconstructive. Cosmetic o

Upper Limb Prosthetics Market (By Component: Prosthetic Arm, Prosthetic Wrist, Prosthetic Shoulder, Prosthetic Elbow, Terminal Devices; By Product: Body Powered Prosthetic Devices, Passive Prosthetic Devices, Hybrid Prosthetic Devices, Myoelectric Prosthetic Devices; By Cause: Vascular Disease and Diabetes, Trauma, Cancer; By End Use: Ambulatory Surgical Centers, Hospitals, Prosthetic Clinics) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global upper limb prosthetics market size is expected to worth US$ 1.9 billion by 2026 and poised to grow at a CAGR around 10.5 % from period 2019 to 2026. The prothetics of the upper limbs have gone a long way from their ancient origins to advanced and advanced protheses of today's moments.  Today, the highest prothesis implants consist of aluminum, plastics and sophisticated composite components. The

MRI-Guided Neurosurgical Ablation Market (By Product: Accessories, MRI-guided Laser Ablation Systems, MRI-guided Focused Ultrasound Systems, MRI-guided Radiofrequency Ablation Systems; By End-use: Clinics, Ambulatory Surgical Centers, Hospitals) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global MRI-guided neurosurgical ablation market is forecasted to grow at a CAGR around 4.3% from period 2019 to 2026 and reach around US$ 5.4 billion by 2026. The report provides analysis of global MRI-guided Neurosurgical Ablation market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights An gr

Self-Monitoring Blood Glucose Devices Market (By Product: Continuous Glucose Monitors, Lancets, Self-monitoring Blood Glucose Meters, Testing Strips; By Application: Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes; By End-Use: Home Usage, Hospitals, Diagnostic Clinics & Centers) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction According to Acumen Research and Consulting, The global self-monitoring blood glucose devices market size is expected to reach US$ 19 billion by 2026 and market is growing at a CAGR of 5 % from 2019 to 2026. Diabetes is a clinical disorder in which the blood glucose level rises owing to the pancreas ' incapacity to generate insulin. Monitoring glucose is one of the most important measures in the leadership of diabetes

Ovarian Cancer Diagnostics Market (By Diagnosis Type: Imaging, Biopsy, Blood Test, Others; By Cancer Type: Germ Cell Tumor, Stromal Cell Tumor, Epithelial Tumor, Others; By End-Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, Others) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction  According to Acumen Research and Consulting, the global ovarian cancer diagnostics market is forecasted to grow at striking CAGR around 5.9 % over the forecast time frame and reach around US$ 1.8 billion by 2026. One of the most prevalent kinds of cancer in females is ovarian cancer. It is a cancer which begins in the ovaries. Ovary is a woman reproductive organ that contains eggs or ova. There are two ovaries i

Cart Summary